X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1162) 1162
Publication (109) 109
Conference Proceeding (62) 62
Book Review (47) 47
Newspaper Article (30) 30
Patent (20) 20
Book / eBook (9) 9
Book Chapter (9) 9
Dissertation (1) 1
Magazine Article (1) 1
Reference (1) 1
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (459) 459
humans (284) 284
male (246) 246
female (209) 209
animals (188) 188
analysis (136) 136
middle aged (117) 117
neurosciences (104) 104
adult (101) 101
aged (92) 92
rats (83) 83
risk factors (75) 75
cannabinoids (68) 68
health aspects (68) 68
immunology (67) 67
pharmacology & pharmacy (64) 64
infectious diseases (63) 63
transplantation (63) 63
mice (62) 62
research (62) 62
environmental sciences (61) 61
engineering, civil (52) 52
surgery (49) 49
disease (45) 45
microbiology (43) 43
brain (42) 42
cardiac & cardiovascular systems (41) 41
basal ganglia (38) 38
spain (37) 37
multidisciplinary sciences (36) 36
endocannabinoids (35) 35
internal medicine (34) 34
care and treatment (33) 33
construction & building technology (33) 33
infection (33) 33
studies (33) 33
treatment outcome (33) 33
young adult (33) 33
infections (32) 32
prospective studies (32) 32
tetrahydrocannabinol (32) 32
management (31) 31
dopamine (30) 30
medicine (30) 30
mortality (30) 30
rats, wistar (30) 30
receptors (30) 30
sediments (30) 30
materials science, multidisciplinary (29) 29
organ transplant recipients (29) 29
anandamide (28) 28
article (28) 28
cell biology (28) 28
marine & freshwater biology (28) 28
usage (28) 28
life sciences (27) 27
medical research (27) 27
patients (27) 27
research article (27) 27
retrospective studies (27) 27
science (27) 27
gene expression (26) 26
kidney transplantation (26) 26
neurons (26) 26
physiological aspects (26) 26
time factors (26) 26
biochemistry & molecular biology (25) 25
disease models, animal (25) 25
dopamine - metabolism (25) 25
epidemiology (25) 25
follow-up studies (25) 25
model (25) 25
neurology (25) 25
activation (24) 24
concrete (24) 24
medicine, experimental (24) 24
mexico (24) 24
adolescent (23) 23
aged, 80 and over (23) 23
cancer (23) 23
cannabinoid (23) 23
clinical neurology (23) 23
expression (23) 23
kidneys (23) 23
prognosis (23) 23
therapy (23) 23
biomedicine (22) 22
cannabinoid receptors (22) 22
cannabinoids - pharmacology (22) 22
critical shear crack theory (22) 22
geosciences, multidisciplinary (22) 22
oncology (22) 22
reinforced concrete (22) 22
development and progression (21) 21
drug therapy (21) 21
neurodegeneration (21) 21
parkinson's disease (21) 21
survival (21) 21
acid amide hydrolase (20) 20
genetic aspects (20) 20
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


NATURE REVIEWS CARDIOLOGY, ISSN 1759-5002, 04/2018, Volume 15, Issue 4, pp. 198 - 198
Journal Article
Nature reviews. Cardiology, ISSN 1759-5002, 04/2018, Volume 15, Issue 4, pp. 198 - 198
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 14, pp. 1327 - 1335
Alogliptin, a new antihyperglycemic agent of the DPP-4 class, was shown to have no significant effect on cardiovascular risk over a median treatment period of... 
INHIBITOR ALOGLIPTIN | MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR SAFETY | MELLITUS | OUTCOMES | MYOCARDIAL-INFARCTION | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Uracil - therapeutic use | Male | Myocardial Infarction - complications | Myocardial Infarction - drug therapy | Uracil - adverse effects | Angina, Unstable - drug therapy | Piperidines - therapeutic use | Angina, Unstable - complications | Piperidines - adverse effects | Cardiovascular Diseases - mortality | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Uracil - analogs & derivatives | Type 2 diabetes | Care and treatment | Acute coronary syndrome | Patient outcomes | Risk factors | Myocardial infarction | Heart attacks | Cardiovascular disease | Angina | Drug development | Hemoglobin | Diabetes mellitus (non-insulin dependent) | Drug dosages | Cerebral infarction | Stroke | Peptidase | Statistical analysis | Diabetes mellitus | Pancreatitis | Committees | FDA approval | Hypoglycemia | Angina pectoris | Studies | Product development | Diabetes | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2018, Volume 379, Issue 22, pp. 2097 - 2107
Among patients who had had an acute coronary syndrome, the risk of death from coronary heart disease, nonfatal myocardial infarction, stroke, or unstable... 
MEDICINE, GENERAL & INTERNAL | MANAGEMENT | MYOCARDIAL-INFARCTION | TASK-FORCE | EFFICACY | SAFETY | LDL | REDUCING LIPIDS | PCSK9 | MONOCLONAL-ANTIBODY | ASSOCIATION | Double-Blind Method | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Hypercholesterolemia - drug therapy | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - blood | Acute Coronary Syndrome - drug therapy | Acute Coronary Syndrome - complications | Anticholesteremic Agents - therapeutic use | Proprotein Convertase 9 - antagonists & inhibitors | Cardiovascular Diseases - epidemiology | Adult | Cholesterol, LDL - blood | Female | Hypercholesterolemia - complications | Aged | Acute coronary syndrome | Diagnosis | Myocardial infarction | Fees & charges | Lipoproteins (low density) | Heart attacks | Lipids | Cardiovascular disease | Angina | Apolipoprotein B | Ischemia | Heart diseases | Drug dosages | Statins | Cerebral infarction | Stroke | Subtilisin | Apolipoproteins | Angina pectoris | Patients | Low density lipoprotein | Coronary artery disease | Cholesterol | Kexin | Monoclonal antibodies | Full text | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Pharmaceuticals | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
Cell Cycle, ISSN 1538-4101, 04/2019, Volume 18, Issue 6-7, pp. 759 - 770
Senescence is a tumor suppressor program characterized by a stable growth arrest while maintaining cell viability. Senescence-associated ribogenesis defects... 
senescence | RPS14/uS11 | RPL22/eL22 | cyclin D1 | Ribosome biogenesis | CDK4 | RPS14 | RPL22 | eL22 | uS11 | L22 | CELL BIOLOGY
Journal Article
Transplant Infectious Disease, ISSN 1398-2273, 10/2015, Volume 17, Issue 5, pp. 637 - 646
Journal Article
Transplant Infectious Disease, ISSN 1398-2273, 12/2018, Volume 20, Issue 6, pp. e12988 - n/a
Journal Article